Centessa Pharmaceuticals (NASDAQ:CNTA) Stock Rating Upgraded by Wall Street Zen
Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Thursday. Other analysts have also issued reports about the company. Chardan Capital began coverage on Centessa Pharmaceuticals in a research report on Thursday, May 8th. They set a […]
Centessa Pharmaceuticals (NASDAQ:CNTA – Get Free Report) was upgraded by Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Thursday. Other analysts have also issued reports about the company. Chardan Capital began coverage on Centessa Pharmaceuticals in a research report on Thursday, May 8th. They set a […]
